Dispersed capsules in lyotropic or lyotropic liquid crystal surfactant phases for enhanced capsule deposition

ABSTRACT

The present invention is a fragrance containing capsule composition dispersed into a lyotropic liquid crystalline surfactant phase as well as a consumer product base containing the same.

This application claim benefit of priority from U.S. application Ser.No. 14/647,754 filed on May 27, 2015, which is the national stage entryunder 35 USC 371 for International Application No. PCT/US2013/071579,filed on Nov. 25, 2013. The international application claims the benefitof priority from U.S. Provisional Application Ser. No. 61/730,246, filedNov. 27, 2012. The contents of the three applications are incorporatedherein by reference in their entirety.

BACKGROUND

A difficulty encountered with using encapsulated fragrances in personalrinse-off compositions (i.e., body wash, conditioner, shampoo) is thatthe fragrance capsules are difficult to deposit onto skin and hair dueto strong interactions with the product surfactants. These surfactantsremove particulates from surfaces and keep the particulates for adhering(soil anti-redeposition) but the surfactants can also alter the surfaceof fragrance capsules. Previous work has shown that polymers can beadded to the capsules and consumer products to enhance deposition on avariety of surfaces. However, the extent of deposition enhancement isaffected by the presence of surfactants and the types of surfactantsused in personal care products.

SUMMARY OF THE INVENTION

The present invention describes the use fragrance containing capsulesthat are dispersed into lyotropic liquid crystalline surfactant phases.It has been surprisingly found that when fragrance containing capsulesare dispersed into lyotropic liquid crystalline surfactant phases beforebeing dispersed into a consumer product, the level of performance issignificantly enhanced versus dispersing the capsules on their own.Thus, this invention is a composition composed of fragrance containingcapsules dispersed into a lyotropic liquid crystalline surfactant phaseand consumer products containing the same.

In one embodiment, the surfactant phase is an oil-continuous liquidcrystalline phase. In accordance with this embodiment, theoil-continuous liquid crystalline phase can include an anionicsurfactant (e.g., a sodium dioctylsulfosuccinate, sodiumditridecylsulfosuccinate, sodium didecylsulfosuccinate, sodiumbis-tridecyl sulfosuccinate, sodium benzene alkyl sulphonate, or blendsthereof) and cationic surfactant (e.g., dioleoyl ammonium methosulfate,methyl bis(hydrogenated tallow amidoethyl)-2-hydroxyethyl ammoniummethyl sulfate, methyl bis(tallow amidoethyl)-2-hydroxyethyl ammoniummethyl sulfate, methyl bis(soya amidoethyl)-2-hydroxyethyl ammoniummethyl sulfate, methyl bis(canola amidoethyl)-2-hydroxyethyl ammoniummethyl sulfate, methyl bis(tallowamido ethyl)-2-tallow imidazoliniummethyl sulfate, dioleoyl ammonium methosulfate, dipalmityl ammoniummethosulfate, or blends thereof). In specific embodiments, theoil-continuous liquid crystalline phase is prepared with sodiumbis-tridecyl sulphosuccinate and dioleoyl ammonium methosulfate; sodiumdioctyl sulfosuccinate and methyl bis (Soya amidoethyl) hydroxyethlylammonium methyl sulfate; or sodium dioctyl sulfosuccinate and dipalmitylammonium methosulfate.

Capsules of this invention include microcapsules, microparticles,nanoparticles, liposomes, vesicles, or spores. In some embodiments,microcapsules can be composed of urea-formaldehyde,melamine-formaldehyde, phenolic-formaldehyde, urea-glutaraldehyde,melamine-glutaraldehyde, phenolic-glutaraldehyde, or combinationsthereof; polyurea, polyurethane, or a combination thereof;acrylate-based hydrogel core-shell capsules orpolyurea/polyurethane-acrylic hybrid core-shell capsules; polyamide andpolyester-based capsules; or silica or silica-derived materials. In someembodiments, the microcapsules are physically or chemically coated witha polymer that facilitates incorporation of the microcapsules into thesurfactant phase. In further embodiments, the microcapsules ornanoparticles are composed of polyethylene, poly vinyl acetate,ethylene-vinyl acetate copolymers, polyacrylates such as copolymers ofmethyl methacrylate, polyurethanes, polyureas, formaldehyde resins,polyesters or polyamide. In yet other embodiments, the spores are plantspores loaded with a fragrance, and optionally sealed with polymers, andthe vesicles are polymersomes.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 shows a phase diagram of the formulation of the invention.

FIG. 2 shows the intensity of fragrance in vapor above hair washed withproducts (shampoo and condition) containing fragrance microcapsules(polyurea (PU) microcapsules) alone or fragrance microcapsules in TRITONX100 (TX) or lyotropic liquid crystalline phase composed of sodiumdioctylsulfo-succinate (AOT). Fragrance microcapsule preparations wereused fresh (0) or after storage for 2 weeks (2). N=13.

FIG. 3 shows the intensity of fragrance achieved via polyurea (PU)microcapsules dispersed in a lyotropic liquid crystalline phase (LLCP;sodium dioctylsulfo-succinate (AOT)), a lamellar phase (LP; AOT), TRITONX100 (TX), or ACCOSOFT (AS) and incorporated into a liquid detergent, ascompared to microcapsules dispersed in the neat liquid detergent(control).

DETAILED DESCRIPTION OF THE INVENTION

It has now been found that the deposition of fragrance capsules ontohair or skin can be enhanced by dispersing these fragrance containingcapsules into lyotropic liquid crystalline surfactant phases beforebeing dispersed into the consumer product. Advantageously, the lyotropicliquid crystalline phase alters the surface of the capsules therebyminimizing alterations of the capsule surface when the capsules areadded to an existing consumer product formulation. This approach notonly takes advantage of electrostatic and hydrogen/dipole interactionsbut also viscous/tacky adhesive forces. Therefore, the present inventionis a composition of fragrance containing capsules dispersed into alyotropic liquid crystalline surfactant phase and consumer productscontaining the same.

For the purposes of this invention, the term “capsules” is intended toinclude microcapsules, microparticles, nanoparticles, liposomes,vesicles, and spores. As known in the art and used herein,microcapsules, microparticles and nanoparticles refers to particles,which are typically solid and contain the fragrance to be deliveredwithin the core of the particle or capsule. Microparticles (ormicrocapsules) and nanoparticles generally differ in size.Microparticles and microcapsules typically have a size range of about 1to about 1000 microns. Nanoparticles typically have a particle sizerange of about 10 to about 1000 nm.

Any permeable capsule wall material can be used in the preparation ofthe microcapsules, microparticles or nanoparticles of this invention.Suitable wall materials include, but are not limited to friable wallmaterials such as urea-formaldehyde, melamine-formaldehyde,phenolic-formaldehyde, urea-glutaraldehyde, melamine-glutaraldehyde,phenolic-glutaraldehyde, or combinations thereof; or polyurea,polyurethane, or a combination thereof. In addition, the microcapsulescan be acrylate-based hydrogel core-shell capsules orpolyurea/polyurethane-acrylic hybrid core-shell capsules. Furthermore,the microcapsules can be polyamide- and polyester-based capsules.Moreover, silica or silica-derived materials, which are typicallyprepared via sol-gel processes, can be used in the preparation ofmicrocapsules of this invention (see, e.g., US 2010/0143422). Capsuleshaving shell walls composed of polyolefin, polysaccaharide, protein,lipid, modified cellulose, gums, polyphosphate, polystyrene, andpolyesters or combinations of these materials are also functional.

Suitable polymers for encapsulation in the present invention includeamino-based prepolymers such as urea-, melamine-, benzoguanamine-, andglycouril-formaldehyde resins and dimethyloldihydroxyethylene urea typeprepolymers. These prepolymers can be used as blends and cross linkerswith polyvinyl alcohol, polyvinyl amines, acrylates (acid functionalitypreferred), amines, polysaccharides, polyureas/urethanes, poly aminoacids, and proteins. Other suitable polymers include polyesters,including biodegradable polyesters, polyamides, polyacrylates andpolyacrylamides, polyvinyl polymer and copolymers with polyacrylates,polyurethanes, polyethers, polyureas, polycarbonates, naturallyoccurring polymers such as, polyanhydrides, polyphosphazines,polyoxazolines, and UV-cured polyolefins.

The present invention also contemplates the use of UV-cured versions ofall the above polymer materials, epoxy-cross linked polyalcohols,polyamines, and polyurethanes/ureas, as well as multiple shell versionsof the above.

As indicated, the microcapsules of this invention can be friable.Friability refers to the propensity of the capsules to rupture or breakopen when subjected to direct external pressures or shear forces. Forthe purposes of this invention, a capsule is “friable” if, whileattached to a treated surface (e.g., a fabric), the microcapsule can beruptured by the forces encountered when the microcapsule-containingsurface is manipulated, e.g., by being worn, handled or ironed therebyreleasing the contents of the microcapsule.

Friable shell-core microcapsules can be prepared by methods such asinterfacial polymerization and polycondensation. See, e.g., U.S. Pat.No. 3,516,941, U.S. Pat. No. 4,520,142, U.S. Pat. No. 4,528,226, U.S.Pat. No. 4,681,806, U.S. Pat. No. 4,145,184; GB 2,073,132; WO 99/17871;and Microencapsulation: Methods and Industrial Applications, Edited byBenita and Simon (Marcel Dekker, Inc. 1996). It is recognized that manyvariations with regard to materials and process steps are possible,however, non-limiting examples of friable shell materials suitable formaking a friable shell of the microcapsule of this invention includeurea-formaldehyde, melamine-formaldehyde, phenol-formaldehyde,amido-aldehyde, gelatin, gelatin/gum arabic blend, polyurethane,polyamides, or combinations thereof.

Methods for preparing capsules with urea formaldehyde, urea aldehyde, oramido-aldehyde are disclosed in, e.g., U.S. Pat. No. 5,204,185, EP 0 443428 A2, U.S. Pat. No. 3,516,941 and EP 0 158 449 A1. Polyurea andpolyurethane microcapsules are known in art for use in the encapsulationof agrochemicals, e.g., herbicides and pesticides (see, e.g., U.S. Pat.No. 6,133,197) and for the release of benefit agents intended forlaundry, washing, cleaning, surface care and personal and skin care(see, e.g., US Patent Application 2012/0148644). In some embodiments,the microcapsules of this invention are physically or chemically coatedwith a polymer to facilitate incorporation into the surfactant phase.Preferably the polymer is water soluble and is nonionic, anionic,cationic, or amphoteric. Those skilled in the art would appreciate thatthe charge of these polymers can be adjusted by changing the pH,depending on the product in which this technology is to be used. Anysuitable method for coating the polymer onto the fragrance containingmicrocapsule can be used. The nature of suitable polymers for assistedcapsule delivery to interfaces depends on the compatibility with thecapsule wall chemistry since there has to be some association to thecapsule wall. This association can be through physical interactions,such as hydrogen bonding, ionic interactions, hydrophobic interactions,electron transfer interactions or, alternatively, the polymer coatingcould be chemically (covalently) grafted to the capsule or particlesurface. Chemical modification of the capsule surface is another way tooptimize anchoring of the polymer coating to capsule surface.Furthermore, the capsule and the polymer need to want to go to thedesired interface and, therefore, need to be compatible with thechemistry (polarity, for instance) of that interface. Therefore,depending on which capsule chemistry and interface (e.g., cotton,polyester, hair, skin, wool) is used, the polymer can be selected fromone or more polymers with an overall zero (amphoteric: mixture ofcationic and anionic functional groups) or net positive charge, based onthe following polymer backbones: polysaccharides, polypeptides,polycarbonates, polyesters, polyolefinic (vinyl, acrylic, acrylamide,poly diene), polyester, polyether, polyurethane, polyoxazoline,polyamine, silicone, polyphosphazine, olyaromatic, poly heterocyclic, orpolyionene, with molecular weight (MW) ranging from about 1,000 to about1000,000,000, preferably from about 5,000 to about 10,000,000. As usedherein, molecular weight is provided as weight average molecular weight.Optionally, these cationic polymers can be used in combination withnonionic and anionic polymers and surfactants, possibly throughcoacervate formation. A more detailed list of cationic polymers that canbe used to coat the encapsulated fragrance is provided in U.S. Pat. Nos.7,119,057 and 7,122,512.

In certain embodiments, the microcapsules or nanoparticles are preparedwith polyethylene, poly vinyl acetate, ethylene-vinyl acetatecopolymers, a polyacrylate such as a copolymer of methyl methacrylate,polyurethane, polyurea, formaldehyde resin, polyester, or polyamide.

Liposomes or vesicles are microscopic spheres having a core surroundedby one or more outer layers made up of lipids arranged in a bi-layerconfiguration (see, generally, Chonn, et al. (1995) Curr. Opin. Biotech.6:698-708). As known in the art, liposomes can be categorized intovarious types: multilamellar (MLV), stable plurilamellar (SPLV), smallunilamellar (SUV) or large unilamellar (LUV) vesicles. Liposomes can beprepared from various lipid compounds, which may be synthetic ornaturally occurring, including phosphatidyl ethers and esters, such asphosphotidylserine, phosphotidylcholine, phosphatidyl ethanolamine,phosphatidylinositol, dimyristoylphosphatidylcholine; steroids such ascholesterol; sphingomyelin; glycerolipids; and other lipids. See, forexample, U.S. Pat. No. 5,833,948.

This invention also includes the use of vesicles, i.e., small enclosedsacs having a bimolecular membrane structure. In some embodiments, thevesicle is a polymersome. A polymersome is vesicle composed of blockcopolymers that include a hydrophobic block and a hydrophilic block.These block copolymers may have a number average molecular weight in therange of from about 2,000 to about 100,000. The hydrophilic block of theblock copolymers may include any polymer for which water is a goodsolvent. Examples of suitable polymers for the hydrophilic blockinclude, but are not limited to, poly(acrylic acid), poly(ethyleneoxide), poly(methacrylic acid), poly(2-acrylamido, 2-methyl propanesulfonic acid), poly(acrylamide), and poly(2-dimethylaminoethylmethacrylate). The hydrophobic block may include any polymer for whichwater is not a good solvent. Examples of suitable hydrophobic polymersfor the hydrophobic block include, but are not limited to,poly(butadiene), poly(styrene), poly(isoprene), poly(ethylene),poly(ethylene propylene), and poly(ethylene butene). The polymersomes ofthis invention may be prepared from block copolymers by any process,including, but are not limited to, film rehydration, electroformation,and solvent injection. Exemplary processes and materials for preparationof polymersomes are described by Discher & Eisenberg (2002) Science297:967-73; US 2012/0231055; PCT/NL2006/000052; U.S. Pat. No. 7,151,077;US 2008/0181939; and US 2005/0003016.

Another capsule of this invention is a spore or pollen grain from aplant or fungus. As is known in the art, pollen grains can be modifiedby removing their natural contents and substituting or loading the corewith a variety of materials including drugs, chemicals and otherpharmacologically active substances. See U.S. Pat. No. 5,013,552. Tomodify solubility, the spore can be coated or sealed with a polymer,e.g., a film-forming material composed of plasticizers, extenders,fillers, and other common excipients. By “film-forming” is meant theproperty of forming a solid film, coating or layer at ambient or roomtemperatures. If the film-forming material is thermoplastic or capableof being melted or liquified at elevated temperatures, it may be appliedto the spore or underlying layer of active substance by spray,immersion, or other means of deposition. Examples of film-formingmaterials include, but are not limited to, polymethylsiloxane,polyacrylamide, polyvinyl pyrrolidone (PVP), polyvinyl alcohol,ethylene/vinyl acetate copolymer, polyesters, polyurethanes,polycarbonates, polystyrene, polymethyl methacrylate, polyvinyl acetate,polyols, polythiols, polyamines, polyethylene, polypropylene,cellulosics such as regenerated cellulose, ethyl cellulose, celluloseacetate butyrate (CAB), fats, waxes, etc. See U.S. Pat. No. 5,275,819.

Encapsulated within the core of the capsules of the invention is one ormore fragrance oils. As referred to herein, the term “fragrance oil”refers to perfume materials and may include single perfume raw materialsor blends of oils. A wide variety of chemicals may be employed as orincluded in the fragrance oil, including materials such as aldehydes andalcohols, as well as some esters and ketones and lactones of highpolarity. More commonly, naturally occurring plant and animal oils andexudates including complex mixtures of various chemical components areknown for use as or inclusion in Fragrance Oils.

Examples of fragrance oils useful herein include, but are not limitedto, animal fragrances such as musk oil, civet, castoreum, ambergris,plant fragrances such as nutmeg extract, cardamom extract, gingerextract, cinnamon extract, patchouli oil, geranium oil, orange oil,mandarin oil, orange flower extract, cedarwood, vetyver, lavandin, ylangextract, tuberose extract, sandalwood oil, bergamot oil, rosemary oil,spearmint oil, peppermint oil, lemon oil, lavender oil, citronella oil,chamomile oil, clove oil, sage oil, neroli oil, labdanum oil, eucalyptusoil, verbena oil, mimosa extract, narcissus extract, carrot seedextract, jasmine extract, olibanum extract, rose extract and mixturesthereof.

Other examples of suitable fragrance oils include, but are not limitedto, chemical substances such as acetophenone, adoxal, aldehyde C-12,aldehyde C-14, aldehyde C-18, allyl caprylate, ambroxan, amyl acetate,dimethylindane derivatives, α-amylcinnamic aldehyde, anethole,anisaldehyde, benzaldehyde, benzyl acetate, benzyl alcohol and esterderivatives, benzyl propionate, benzyl salicylate, borneol, butylacetate, camphor, carbitol, cinnamaldehyde, cinnamyl acetate, cinnamylalcohol, cis-3-hexanol and ester derivatives, cis-3-hexenyl methylcarbonate, citral, citronellol and ester derivatives, cumin aldehyde,cyclamen aldehyde, cyclo galbanate, damascones, decalactone, decanol,estragole, dihydromyrcenol, dimethyl benzyl carbinol,6,8-dimethyl-2-nonanol, dimethyl benzyl carbinyl butyrate, ethylacetate, ethyl isobutyrate, ethyl butyrate, ethyl propionate, ethylcaprylate, ethyl cinnamate, ethyl hexanoate, ethyl valerate, ethylvanillin, eugenol, exaltolide, fenchone, fruity esters such as ethyl2-methyl butyrate, galaxolide, geraniol and ester derivatives, helional,2-heptonone, hexenol, α-hexylcinnamic aldehyde, hydroxycitronellal,indole, isoamyl acetate, isoeugenol acetate, ionones, isoeugenol,isoamyl iso-valerate, iso E super, limonene, linalool, lilial, linalylacetate, lyral, majantol, mayol, melonal, menthol, p-methylacetophenone,methyl anthranilate, methyl cedrylone, methyl dihydrojasmonate, methyleugenol, methyl ionone, methyl-β-naphthyl ketone, methylphenylcarbinylacetate, mugetanol, γ-nanalactone, octanal, phenyl ethyl acetate,phenyl-acetaldehyde dimethyl acetate, phenoxyethyl isobutyrate, phenylethyl alcohol, pinenes, sandalore, santalol, stemone, thymol, terpenes,triplal, triethyl citrate, 3,3,5-trimethylcyclohexanol, γ-undecalactone,undecenal, vanillin, veloutone, verdox and mixtures thereof.

Suitable fragrance oils can be found in U.S. Pat. Nos. 4,145,184,4,209,417, 4,515,705, and 4,152,272, all of which are incorporatedherein by reference.

As indicated, deposition of fragrance capsules onto surfaces can beenhanced by dispersing the fragrance containing capsules into lyotropicliquid crystalline surfactant phases before being dispersed into theconsumer product. In one embodiment, the capsule is dispersed in alyotropic liquid crystalline phase, such as a cubic, hexagonal andinverse hexagonal phase. In accordance with particular aspects of thisembodiment, the lyotropic liquid crystalline surfactant phase is anoil-continuous liquid crystalline phase.

The liquid crystalline phase of the invention is formed by combining thefragrance containing capsule with low Hydrophilic-lipophilic balance(HLB), water insoluble surfactants to obtain a phase which isoil-continuous or bicontinuous rather than water continuous, wherein thephases do not extend from the micellar phase (FIG. 1). The phases ofthis invention extend from the “inverse micellar” (water cores in oilmedia, rather than the reverse). Some do and some do not rotate planepolarized light. Using the present formulation, two or more additionalphases to the micellar phase can occur. The continuous phase can bedetermined experimentally by testing the conductivity with aconductivity meter or using an impedance analyzer.

In general, the liquid crystalline phase of the invention is prepared bycombining one or more cationic surfactant(s) and one or more anionicsurfactant(s) with the fragrance containing capsules. The composition ofthe invention may include from about 20% wt to about 70% wt surfactant,preferably from about 30% wt to about 60% wt, more preferably from about30% wt to about 45% wt, even more preferably from about 35% wt to about45% wt, more preferably still from about 40% wt.

Anionic surfactants which may be used in this invention include alkylsulfates, alkyl ether sulfates, sulfated monoglycerides, sulfonatedolefins, alkyl aryl sulfonates, primary or secondary alkane sulfonates,alkyl sulfosuccinates, acyl taurates, acyl isethionates, alkylglycerylether sulfonate, sulfonated methyl esters, sulfonated fattyacids, alkyl phosphates, acyl glutamates, acyl sarcosinates, alkylsulfoacetates, acylated peptides, alkyl ether carboxylates, acyllactylates, and combinations thereof. In some embodiments, the anionicsurfactant is a sulfosuccinate or sulfate. Sulfosuccinates include, butare not limited to the dialkylsulfosuccinates such as sodiumdioctylsulfosuccinate, sodium ditridecylsulfosuccinate, sodiumdidecylsulfosuccinate, sodium bis-tridecyl sulfosuccinate, or blendsthereof. In particular embodiments, the anionic surfactant is sodiumbis-tridecyl sulfosuccinate or sodium dioctyl sulfosuccinate.Sulphonates of use in this invention, include, but are not limited tosodium benzene alkyl sulphonate.

The formulation according to the invention may include from about 1% wtto about 70% wt anionic surfactant, preferably from about 1% wt to about60% wt, more preferably from about 10% wt to about 50% wt, even morepreferably from about 10% wt to about 45% wt, more preferably still fromabout 15% to about 50% wt.

Cationic surfactants which may be employed according to the inventioninclude, e.g., fatty amines, di-fatty quaternary amines, trifattyquaternary amines, imidazolinium quaternary amines, and combinationsthereof. Suitable cationic surfactants are particularly cetyl trimethylammonium chloride, palmitamidopropyltrimonum chloride,dipalmitoyltrimonium chloride, distearyldimonium chloride,dipalmitoylethylhydroxyethylmonium chloride, dioleoylethyl ammoniummethosulfate, dioleoylethyl hydroxyethylmonium methosulfate,dilinolamidopropyldimonium chloride, dioleylethyl hydroxyethylmoniumchloride, dipalmitoylethyldimonium chloride and or didodecyl dimethylammonium chloride. In particular embodiments, the cationic surfactant isdioleoyl ammonium methosulfate. In other embodiments, the cationicsurfactant is methyl bis(hydrogenated tallow amidoethyl)-2-hydroxyethylammonium methyl sulfate, methyl bis(tallow amidoethyl)-2-hydroxyethylammonium methyl sulfate, methyl bis(soya amidoethyl)-2-hydroxyethylammonium methyl sulfate, methyl bis(canola amidoethyl)-2-hydroxyethylammonium methyl sulfate, methyl bis(tallowamido ethyl)-2-tallowimidazolinium methyl sulfate, dioleoyl ammonium methosulfate, ordidodecyl dimethyl ammonium chloride, dipalmityl ammonium methosulfate,or blends thereof.

The formulation according to the invention may include from about 1% wtto about 30% wt cationic surfactant, preferably from about 5% wt toabout 30% wt, more preferably from about 10% wt to about 25% wt, evenmore preferably from about 12% wt to about 25% wt.

As mentioned, the surfactant of the formulation of this inventionadvantageously includes both anionic and cationic surfactants. Withanionic-cationic binary surfactant systems, oil continuous phases occurupon addition of water and oil. These depend strongly on surfactantratio, which are experimentally determined. However, total surfactantand oil ratios are the same as for single surfactant systems.

The ratio of a lyotropic liquid crystalline surfactant phase to capsuledispersion is desirably in the range from about 99:1 to about 10:90,preferably in the range from about 99:1 to about 25:75, more preferredin the range from about 99:1 to about 40:60.

In certain embodiments, the formulation of this invention also includesan aqueous component such as water. Typically, the aqueous component isfrom about 0% wt to about 30% wt of the formulation, preferably fromabout 10% wt to about 30% wt, more preferably from about 15% wt to about30% wt, even more preferably from about 20% wt to about 25% wt.

In some embodiments, the fragrance containing capsule is dispersed intoa concentrated lyotropic liquid crystalline phase prior to introductionof the same into a consumer product. In another embodiment, anon-organized surfactant phase is combined with a fragrance containingcapsule, wherein upon addition of the mixture to a consumer product suchas a shampoo or conditioner, a lyotropic liquid crystalline surfactantphase with embedded capsules is formed via the water in the consumerproduct. In an alternative embodiment, the surfactant phase may becreated using the water phase in the capsule dispersion such that thewater phase of the dispersion is a low viscosity microemulsion. Whenthis dispersion is added to the consumer product at particular levels,the desired viscous/dense/organized phases are formed with the capsulesembedded therein. The advantage of this approach is that the dispersioncan be delivered as a one-stop solution with manageable viscousproperties.

In a further embodiment, cationic or amphoteric polymers or blends ofcationic and anionic and amphoteric polymers are added to the consumerproduct base that contains the dispersed viscous/dense/organizedcapsule-containing phases in order to further enhance deposition of thedense phase/capsules particulates. Polymers of use in this embodimentinclude, but are not limited to those disclosed in U.S. Pat. No.7,119,057, U.S. Pat. No. 7,632,789, US 2012/0093899 A1 and US2012/0148644A1. Substantivity of these polymers may be further improvedthrough formulation with cationic, amphoteric and nonionic surfactantsand emulsifiers, or by coacervate formation between surfactants andpolymers or between different polymers. Combinations of polymericsystems (including those mentioned previously) may be used for thispurpose as well as those disclosed in EP 1995/000400185. Furthermore,polymerization of the monomers listed above into a block, graft or star(with various arms) polymers can often increase the substantivity towardvarious surfaces. The monomers in the various blocks, graft and arms canbe selected from the various polymer classes listed in thisspecification.

The preferred cationically charged materials include cationicallymodified starch and cationically modified guar, polymers comprising polydiallyl dimethyl ammonium halides (PolyDADMAC), and copolymers of DADMACwith vinyl pyrrolidone, acrylamides, imidazoles, imidazolinium halides,and the like. For instance, Polyquaternium-6, 7, 22 and 39, allavailable from Ondeo Nalco. Another set of preferred cationic polymersare those composed using the MAPTAC cationic monomer like MERQUAT 2001and MERQUAT 2003PR and MAQUAT PQ125. A further preferred set of polymersare combinations of cationic polymers (containing quarternary monomerslike DADMAC and MAPTAC) and polyamines like poly vinyl amine derivativesand polyethylene imine derivatives.

A preferred cationic starch has a molecular weight of from about 100,000to about 500,000,000, preferably from about 200,000 to about 10,000,000and most preferably from about 250,000 to about 5,000,000. The preferredcationic starch products are HI-CAT CWS42 and HI-CAT 02 and arecommercially available from ROQUETTE AMERICA, Inc.

A preferred cationic guar has a molecular weight of from about 50,000 toabout 5,000,000. The preferred cationic guar products are Jaguar C-162and Jaguar C-17 and are commercially available from Rhodia Inc.

The level of cationic polymer is from about 1% to about 3000%,preferably from about 5% to about 1000% and most preferably from about10% to about 500% of the fragrance containing compositions, based on aratio with the fragrance on a dry basis.

When the capsule and crystalline phase structure is re-dispersed intosurfactant containing bases, like fabric softener, shower gels, shampoosand liquid detergents, the capsule and crystalline phase is expected toretain its structure so that is not completely dissolved or solubilizedin the product base. When the product is used, in a wash, rinseapplication, the fragrance capsule that are tied up in the liquidcrystal or semi-solid phase are expected to deposit onto skin, hair,fabric or other surfaces. This effect causes the fragranced capsules tooccur at higher levels on skin, fabric hair, etc. following a wash orrinse procedure thereby allowing for possible higher deposition andsubstantivity of fragranced capsules that a consumer may notice andappreciate.

Accordingly, the composition of this invention finds particular use inthe consumer product bases, e.g., fabric care products, includingdetergents, fabric conditioners, and the like; as well as personal careproducts which include shampoos, body wash, conditioners, hair rinses,hair refreshers, body washes, soaps, anti-perspirants, deodorants andthe like. These products are well known in the art. For example, fabricsoftener systems are described in U.S. Pat. Nos. 6,335,315, 5,674,832,5,759,990, 5,877,145, 5,574,179; 5,562,849, 5,545,350, 5,545,340,5,411,671, 5,403,499, 5,288,417, 4,767,547, 4,424,134. Shampoo andconditioners that can employ the present invention include U.S. Pat.Nos. 6,162,423, 5,968,286, 5,935,561, 5,932,203, 5,837,661, 5,776,443,5,756,436, 5,661,118, 5,618,523, 5,275,755, 5,085,857, 4,673,568,4,387,090 and 4,705,681.

In certain embodiments, the final consumer product or composition may bein the form of an oil, a gel, a solid stick, a lotion, a cream, a milk,an aerosol, a spray, a powder, a foam, a shampoo, a body wash, a soapbar, a hair conditioner, a lacquer or a make-up.

Consumer product compositions according to the invention may alsoinclude vitamins and derivatives thereof, sunscreens, preservatives,chelators and sequestrants and aesthetic agents such as dyes, mica,titanium dioxide, ethylene glycol distearate (EGDS).

The invention is described in greater detail by the followingnon-limiting examples.

EXAMPLE 1 Cubic Liquid Crystalline Phase

Oil-continuous liquid crystalline phase formulations (#1 and #2), whichform cubic liquid crystalline phases, were prepared by adding a polyureacapsule slurry, which contains water necessary for the phase to formin-situ, to the surfactant mixture (Table 1).

A mixture of 75% tetraethoxy nonyl phenol and 25% sodium benzene alkylsulphonate were mixed and heated to 50° C. To 100 grams of thissurfactant mixture was added 43 grams of capsule slurry containing 50%water. The resultant preparation, a cubic liquid-crystalline phase withpolyurea capsules dispersed and entrapped in the phase was obtained. Onegram of this phase was added to shampoo base and mixed. The fragrancereleased from capsules was measured after use and was found to be higherthan from a shampoo containing an equivalent amount of capsule slurrywithout the surfactant phase.

TABLE 1 Surfactant Co- Form. 1 2 surfactant #1* 20% sodium 46.5% tetra3.5% 30% polyurea benzene alkyl ethoxy nonyl dodecanol capsulesulphonate phenol slurry (50% water) #2 39% Dioleoyl 24% Sodium 7% 30%polyurea ammonium bis-tridecyl rhodinol capsule methosulfatesulphosuccinate slurry (50% water) *This formulation is particularlysuited for a shower gel or shampoo base.

EXAMPLE 2 Inverse Hexagonal Phase

Oil-continuous liquid crystalline phase formulations (#3, #4), whichform an inverse hexagonal phase, were prepared with polyurea capsuleslurry supplying the water necessary to form the phase and entrap thecapsules (Table 2). The resultant inverse hexagonal phase containing thecapsules was added to a hair conditioner base.

TABLE 2 Surfactant Polyurea Fragrance capsule oil/co- slurry Form. 1 2surfactant (%) #3 43% Sodium 7% methyl bis 20% 30% dioctylsulfo- (Soyasuccinate amidoethyl) hydroxyethlyl ammonium methyl sulfate #4 52.5%methyl 17.5% 30% bis (Soya oleic acid amidoethyl) hydroxyethlyl ammoniummethyl sulfate

In this example, the oil-surfactant mixture absorbed water uponintroduction of the water containing capsule slurry to form the oilcontinuous lyotropic liquid crystal. The resultant preparation was addedto hair conditioner. After use and upon combing, more fragrance wasreleased above the hair than from a control containing the same amountof capsule in the absence of the inverse hexagonal phase.

EXAMPLE 3 Performance of Polyurea Microcapsules in Shampoo and HairConditioner

A shampoo application procedure was used to test the performance ofpolyurea microcapsules. Two bundles of hair (4 strands of hair/bundle)were wet under water and lightly squeezed to remove excess water. Thehair was placed onto a balance and 2 grams of shampoo were directlyapplied onto the wet hair (1 gram of product/bundle). The hair waslathered between palms 10× clockwise and counterclockwise, keeping thewax part of the swatches between two fingers so that the wax was notspread over the surface of the hair. The hair swatches were allowed tostand for 15 seconds and subsequently rinsed under a stream (1gallon/minute) of water (100° F./38° C.) for 45 seconds. The hair wasgently squeezed to remove excess water and hung overnight to dry.

A hair conditioner application procedure was also used to test theperformance of polyurea microcapsules. Two bundles of hair (4 strands ofhair/bundle) were wet under water and lightly squeezed to remove excesswater. The hair was placed onto a balance and 2 grams of unfragrancedshampoo were directly applied onto the wet hair (1 gram ofproduct/bundle). The hair was lathered between palms 10× clockwise andcounterclockwise, keeping the wax part of the swatches between twofingers so that the wax was not spread over the surface of the hair. Thehair swatches were allowed to stand for 15 seconds and subsequentlyrinsed under a stream of water (1 gallon/minute; 100° F./38° C.) forseconds. The procedure was repeated with hair conditioner, the hair wasgently squeezed to remove excess water and hung overnight to dry.

Increased levels of fragrance in vapor above hair washed were achievedwith products containing fragrance microcapsules in lyotropic liquidcrystalline phases (FIG. 2).

EXAMPLE 4 Performance Enhancement of Polyurea Microcapsules in LiquidDetergent

A liquid detergent application procedure was used to test theperformance of polyurea microcapsules. The results of this analysis arepresented in FIG. 3. This analysis indicated that polyurea microcapsulesdispersed in an organized inverse hexagonal lyotropic liquid crystallinesurfactant phase outperformed polyurea microcapsules dispersed in neatliquid detergent.

What is claimed is:
 1. A composition comprising fragrance containingcapsules dispersed into a lyotropic liquid crystalline surfactant phase,wherein the lyotropic liquid crystalline surfactant phase is anoil-continuous liquid crystalline phase.
 2. The composition of claim 1,wherein the oil-continuous liquid crystalline phase comprises an anionicsurfactant and cationic surfactant.
 3. The composition of claim 2,wherein the anionic surfactant comprises a sodium dioctylsulfosuccinate,sodium ditridecylsulfosuccinate, sodium didecylsulfosuccinate, sodiumbis-tridecyl sulfosuccinate, sodium benzene alkyl sulphonate, or blendsthereof.
 4. The composition of claim 2, wherein the cationic surfactantcomprises dioleoyl ammonium methosulfate, methyl bis(hydrogenated tallowamidoethyl)-2-hydroxyethyl ammonium methyl sulfate, methyl bis(tallowamidoethyl)-2-hydroxyethyl ammonium methyl sulfate, methyl bis(soyaamidoethyl)-2-hydroxyethyl ammonium methyl sulfate, methyl bis(canolaamidoethyl)-2-hydroxyethyl ammonium methyl sulfate, methylbis(tallowamido ethyl)-2-tallow imidazolinium methyl sulfate, dioleoylammonium methosulfate, dipalmityl ammonium methosulfate, or blendsthereof.
 5. The composition of claim 2, wherein the anionic surfactantis sodium bis-tridecyl sulphosuccinate and the cationic surfactant isdioleoyl ammonium methosulfate.
 6. The composition of claim 2, whereinthe anionic surfactant is sodium dioctyl sulfosuccinate and the cationicsurfactant is methyl bis (Soya amidoethyl) hydroxyethlyl ammonium methylsulfate.
 7. The composition of claim 2, wherein the anionic surfactantis sodium dioctyl sulfosuccinate and the cationic surfactant isdipalmityl ammonium methosulfate.
 8. The composition of claim 1, whereinthe capsules are microcapsules, microparticles, nanoparticles,liposomes, vesicles, spores or a combination thereof.
 9. The compositionof claim 8, wherein the microcapsules comprise urea-formaldehyde,melamine-formaldehyde, phenolic-formaldehyde, urea-glutaraldehyde,melamine-glutaraldehyde, phenolic-glutaraldehyde, polyurea,polyurethane, silica or a silica-derived material, or combinationsthereof.
 10. The composition of claim 8, wherein the microcapsulescomprise polyurea, polyurethane, or a combination thereof.
 11. Thecomposition of claim 8, wherein the microcapsules are acrylate-basedhydrogel core-shell capsules, polyurea/polyurethane-acrylic hybridcore-shell capsules, or polyamide and polyester-based capsules.
 12. Thecomposition of claim 8, wherein the microcapsules are polyamide andpolyester-based capsules.
 13. The composition of claim 8, wherein themicrocapsules comprise silica or silica-derived materials.
 14. Thecomposition of claim 8, wherein the microcapsules are physically orchemically coated with a polymer that facilitates incorporation of themicrocapsules into the surfactant phase.
 15. The composition of claim 8,wherein the microcapsules or nanoparticles comprise polyethylene, polyvinyl acetate, ethylene-vinyl acetate copolymers, polyacrylate,polyurethane, polyurea, formaldehyde resin, polyester, or polyamide. 16.The composition of claim 8, wherein the spores are plant sporesoptionally coated with a polymer.
 17. The composition of claim 8,wherein the vesicles are polymersomes.
 18. A consumer product comprisingthe composition of claim
 1. 19. The consumer product of claim 18,wherein said product is prepared by (a) mixing a non-organizedsurfactant phase with a dispersion comprising fragrance containingcapsules, and (b) adding said mixture to a consumer product therebyforming a consumer product with fragrance containing capsules dispersedinto a lyotropic liquid crystalline surfactant phase.
 20. The consumerproduct of claim 18, wherein said product is prepared by mixing aconsumer product with fragrance containing capsules dispersed into alyotropic liquid crystalline surfactant phase.
 21. The consumer productof claim 18, further comprising a cationic or amphoteric polymer, orblend thereof.